Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
Tickers ALNY ETON IBB NVS
Tags PFE SNY Trading Ideas
From Benzinga
Why Lineage Cell Therapeutics Zoomed Higher Today
Tickers LCTX RHHBY
Tags LCTX Recent Press Releases RHHBY
From Motley Fool
Lineage, Genentech Ink Cell Therapy Licensing Pact For Ocular Diseases
Tickers LCTX RHHBF RHHBY RHHVF
Tags LCTX Age/Related Macular Degeneration RHHVF
From Benzinga
These OTC Securities Had the Most Trading Activity in November
Tickers ADDYY AYRWF BNPQY ETHE
Tags Benzinga IPIX BNPQY
From Benzinga
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
Tickers ASRT ATRS BIIB CALT
Tags NVAX XFOR VALN
From Benzinga
Novartis Launches New Share Buyback Program Of Up To $15B
Tickers NVS RHHBF RHHBY RHHVF
Tags RHHBY Biotech Benzinga
From Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
Tickers AVIR RHHBF RHHBY RHHVF
Tags General Contracts Benzinga
From Benzinga
Roche's Polivy Combo Boosts Survival In Early-Stage Lymphoma Patients
Tickers RHHBF RHHBY RHHVF
Tags Trading Ideas News RHHVF
From Benzinga
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
Tickers APTO ATRA AZN BLU
Tags MRNA ATRA General
From Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
Tickers RHHBF RHHBY RHHVF
Tags Biotech Phase 2 Trial RHHBY
From Benzinga
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
Tickers ABBV ALLO ARGX AZN
Tags CLLS BMY RETA
From Benzinga
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
Tickers BMY INFI RHHBF RHHBY
Tags Phase 2 Trial RHHBY Biotech
From Benzinga
Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer
Tickers RHHBF RHHBY RHHVF
Tags Biotech Phase 2 Trial RHHBY
From Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
Tickers BRK-A BRK-B HALO LGVN
Tags BRK/A PRTA Market News
From InvestorPlace
Europe Approves Roche's Tocilizumab For Patients With Severe COVID-19
Tickers RHHBF RHHBY RHHVF
Tags FDA RHHBY Biotech
From Benzinga
Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients
Tickers IMCR RHHBF RHHBY RHHVF
Tags Biotech RHHBY Solid Tumor
From Benzinga
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
Tickers ADAP AGEN ALPMY GSK
Tags RHHBY ALPMY OCGN
From Motley Fool
Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests
Tickers ABT BDX CI CVS
Tags BDX RHHVF Health Care
From Benzinga
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
Tickers ALPMF ALPMY NVS RHHBF
Tags Health Care RHHVF Trading Ideas
From Benzinga
52 Biggest Movers From Yesterday
Tickers ACET AERC AIH ANNX
Tags APOG BLCT IACB
From Benzinga
35 Stocks Moving In Tuesday's Mid-Day Session
Tickers ADAG ADGI AERC ARRY
Tags Movers LGVN CFRX
From Benzinga
ImmunoGen Shares Rally After Ovarian Cancer Trial Meets Primary Endpoint Goal
Tickers IMGN RHHBY
Tags RHHBY Biotech why it's moving
From Benzinga
As FINRA's OTC Bulletin Board Closes Down, OTC Markets Group Becomes the Main Gateway Into the Regulated Over-the-Counter Market
Tickers ADDYY DANOY OTCM RHHBY
Tags Partner Content Benzinga OTCM
From Benzinga
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
Tickers BIIB RHHBY
Tags RHHBY Market News Recent Press Releases
From Motley Fool
Detecting Early Cancer Screening Stocks At An Early Stage Is Critical
Tickers BMKDF GH MRNA PFE
Tags Market News RHHBY Personal Finance
From Benzinga
1 Cancer Stock on Buyout Watch in 2022
Tickers AMGN AZN BIIB BMY
Tags CRDF GILD SNY
From Motley Fool
Why Regeneron's Results for Its COVID Antibody Therapy Won't Boost Sales Much
Tickers MRK PFE REGN RHHBY
Tags RHHBY MRK PFE
From Motley Fool
Ocugen Stock: Bull vs. Bear
Tickers BIIB EDIT JNJ MRNA
Tags EDIT BIIB NVAX
From Motley Fool
Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer
Tickers RHHBF RHHBY RHHVF
Tags RHHBY FDA Phase 2 Trial
From Benzinga
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
Tickers ALNY BIIB BMRN DRNA
Tags RHHBF Movers Long Ideas
From Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.